Parexel and Japanese Foundation for Cancer Research Announce Strategic Alliance
10. Januar 2024 08:55 ET
|
Parexel International LLC
DURHAM, N.C. and TOKYO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
Parexel Named “Best Contract Research Organization” at 19th Annual Scrip Awards
17. November 2023 07:30 ET
|
Parexel International LLC
DURHAM, N.C., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Named 2023 Healthcare Businesswomen’s Association ACE Award Honoree
08. November 2023 08:55 ET
|
Parexel International LLC
DURHAM, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Global Investigative Sites Recognize Parexel with the 2023 Society for Clinical Research Sites Eagle Award
12. Oktober 2023 08:55 ET
|
Parexel International LLC
DURHAM, N.C., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel’s Amy McKee, M.D. Named to 2023 PharmaVoice 100
20. September 2023 08:55 ET
|
Parexel International LLC
DURHAM, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Appoints Gwyn Bebb, BM, BCh., Ph.D., to Lead Oncology Clinical Development
19. September 2023 08:55 ET
|
Parexel International LLC
DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development
15. August 2023 07:00 ET
|
Parexel International LLC
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets ...
Parexel Announces Updates to Board of Directors
23. Juni 2023 08:49 ET
|
Parexel International LLC
Goldman Sachs’ Partner, Global co-Head of Private Equity Michael Bruun joins as new Director, succeeding current Goldman Sachs Board member Jo Natauri who is retiring from the firm at the end of the...
Parexel Rated “Top CRO to Work With” in 2023 WCG CenterWatch Global Site Relationship Benchmark Survey for Second Straight Time
31. Mai 2023 09:00 ET
|
Parexel International LLC
DURHAM, N.C., May 31, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Appoints Scott Smith, M.D., Ph.D. as New Head of Hematology
19. April 2023 09:00 ET
|
Parexel International LLC
DURHAM, N.C., April 19, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...